Cytokinetics

(NASDAQ) CYTK

Current Price$63.37

Market Cap$7.80B

Since IPO (2004)-34%

5 Year+149%

1 Year+48%

1 Month-5%

Cytokinetics Financials at a Glance

Market Cap

$7.80B

Revenue (TTM)

$88.04M

Net Income (TTM)

$784.96M

EPS (TTM)

$-6.53

P/E Ratio

-9.70

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$63.37

Volume

105,754

Open

$64.48

Price

$63.37

Volume

105,754

Open

$64.48

Previous Close

$63.37

Daily Range

$62.92 - $65.27

52-Week Range

$29.31 - $70.98

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$63.37

Volume

105,754

Open

$64.48

Previous Close

$63.37

Daily Range

$62.92 - $65.27

52-Week Range

$29.31 - $70.98

CYTK News

Cytokinetics Insider Exercises Options Worth Over $920,000 as Heart Drug Hits the Market

Sara AppinoMar 9, 2026

This Cytokinetics Director Sold 5,000 Shares in November. Is It Time to Dump the Biopharmaceutical Stock?

Sarah SidlowDec 19, 2025

Page 1

CYTK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cytokinetics

Industry

Biotechnology

Sector

Health Care

Employees

673

CEO

Robert I. Blum, MBA

Website

www.cytokinetics.com

Headquarters

South San Francisco, CA 94080, US

CYTK Financials

Key Financial Metrics (TTM)

Gross Margin

-22%

Operating Margin

-7%

Net Income Margin

-9%

Return on Equity

Return on Capital

-50%

Return on Assets

-55%

Earnings Yield

-10.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.80B

Shares Outstanding

123.16M

Volume

105.75K

Avg. Volume

1.89M

Financials (TTM)

Gross Profit

$77.91M

Operating Income

$612.26M

EBITDA

$775.27M

Operating Cash Flow

$510.01M

Capital Expenditure

$24.81M

Free Cash Flow

$534.82M

Cash & ST Invst.

$882.22M

Total Debt

$1.28B

Cytokinetics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$17.75M

+4.9%

Gross Profit

$14.89M

+119.4%

Gross Margin

83.89%

N/A

Market Cap

$7.80B

N/A

Market Cap/Employee

$15.67M

N/A

Employees

498

N/A

Net Income

$183.03M

-22.0%

EBITDA

$180.35M

-44.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$402.02M

-239.9%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$1.22B

+61.4%

Short Term Debt

$60.29M

+97.7%

Return on Assets

-55.10%

N/A

Return on Invested Capital

-50.10%

N/A

Free Cash Flow

$148.29M

-121.8%

Operating Cash Flow

$142.65M

-117.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ABVXAbivax S.A.

ABVXAbivax S.A.$117.61+0.20%

HALOHalozyme Therapeutics, Inc.

HALOHalozyme Therapeutics, Inc.$63.96+0.47%

MTSRMetsera, Inc.

MTSRMetsera, Inc.$70.50-0.35%

NUVLNuvalent, Inc.

NUVLNuvalent, Inc.$99.04-1.24%

MRUSMerus N.V.

MRUSMerus N.V.$90.00+0.00%

RYTMRhythm Pharmaceuticals, Inc.

RYTMRhythm Pharmaceuticals, Inc.$81.81+0.55%

CORTCorcept Therapeutics Incorporated

CORTCorcept Therapeutics Incorporated$51.42+10.53%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About CYTK

What is the current price of Cytokinetics?

Cytokinetics is trading at $63.37 per share.

What is the 52-week range for Cytokinetics?

Over the past 52 weeks, Cytokinetics has traded between $29.31 and $70.98.

How much debt does Cytokinetics have?

As of the most recent reporting period, Cytokinetics reported total debt of $1.28B.

How much cash does Cytokinetics have on hand?

Cytokinetics reported $125.63M in cash and cash equivalents in its most recent financial results.

What is Cytokinetics’s dividend yield?

Cytokinetics does not currently have a dividend yield.

Cytokinetics

Cytokinetics Financials at a Glance

CYTK News

Cytokinetics Insider Exercises Options Worth Over $920,000 as Heart Drug Hits the Market

This Cytokinetics Director Sold 5,000 Shares in November. Is It Time to Dump the Biopharmaceutical Stock?

Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares

CYTK Earnings Jump 3,065%

Why Cytokinetics Stock Was a Nearly 5% Winner Today

2 Incredible Growth Stocks to Buy Right Now

Here's Why Cytokinetics Is Rocketing Higher Today

Here's Why Cytokinetics Is Skyrocketing 24.5% Today

CYTK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cytokinetics

CYTK Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cytokinetics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CYTK

What is the current price of Cytokinetics?

What is the 52-week range for Cytokinetics?

How much debt does Cytokinetics have?

How much cash does Cytokinetics have on hand?

What is Cytokinetics’s dividend yield?

Premium Investing Services